Arcus Bio Names Rekha Hemrajani Chief Operating & Financial Officer

Rekha Hemrajani has been appointed chief operating and financial officer of Arcus Biosciences (NYSE: [[ticker:RCUS]]). She joins the Hayward, CA, company from FLX Bio, where she was chief operating officer. Hemrajani’s experience also includes executive roles at 3-V Biosciences, Onyx Pharmaceuticals, and Exelixis (NASDAQ: [[ticker:EXEL]]). Arcus has a number of experimental cancer immunotherapies in early-stage clinical testing. Last year, the company raised $120 million in an IPO to support research and development.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.